Studies on the mechanism of the hypotensive action of SQ-14225, an angiotensin-converting enzyme inhibitor in anesthetized dogs. 1979

B S Jandhyala, and P Nandiwada, and J P Buckley, and M F Lokhandwala

Intravenous administration of SQ-14225, an angiotensin-converting enzyme inhibitor, to pentobarbital-anesthetized dogs resulted in significant decrease in the arterial blood pressure with no changes in the heart rate. Pressure-flow curves obtained in the perfused hind limb vasculature were shifted significantly to the right following SQ-14225 indicating a decrease in the hind limb vascular resistance. Neither the denervation of the hind limb nor bilateral nephrectomy prevented the decrease in the hind limb vascular resistance produced by SQ-14225 indicating that the vasodilator action of this agent was unrelated to either the sympathetic nervous system or the renal renin-angiotensin system. The reflex vasodilatation in the hind limb observed during the administration of pressor agents was significantly attenuated by SQ-14225. Similarly this agent also antagonized the reflex increases in the systemic blood pressure, hind limb perfusion pressure and heart rate observed during bilateral carotid occlusion. These results suggest that the hypotensive action of SQ-14225 in the pentobarbital-anesthetized dog may be unrelated to the renal renin-angiotensin system.

UI MeSH Term Description Entries
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D010424 Pentobarbital A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) Mebubarbital,Mebumal,Diabutal,Etaminal,Ethaminal,Nembutal,Pentobarbital Sodium,Pentobarbital, Monosodium Salt,Pentobarbitone,Sagatal,Monosodium Salt Pentobarbital
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006614 Hindlimb Either of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. (From Storer et al., General Zoology, 6th ed, p73) Hindlimbs
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

B S Jandhyala, and P Nandiwada, and J P Buckley, and M F Lokhandwala
July 1982, The Journal of pharmacology and experimental therapeutics,
B S Jandhyala, and P Nandiwada, and J P Buckley, and M F Lokhandwala
February 1980, Japanese journal of pharmacology,
B S Jandhyala, and P Nandiwada, and J P Buckley, and M F Lokhandwala
June 1979, Endocrinologia japonica,
B S Jandhyala, and P Nandiwada, and J P Buckley, and M F Lokhandwala
June 1980, Acta endocrinologica,
B S Jandhyala, and P Nandiwada, and J P Buckley, and M F Lokhandwala
May 1978, The New England journal of medicine,
B S Jandhyala, and P Nandiwada, and J P Buckley, and M F Lokhandwala
April 1982, Nihon Jinzo Gakkai shi,
B S Jandhyala, and P Nandiwada, and J P Buckley, and M F Lokhandwala
January 1981, Nephron,
B S Jandhyala, and P Nandiwada, and J P Buckley, and M F Lokhandwala
August 1974, Lancet (London, England),
B S Jandhyala, and P Nandiwada, and J P Buckley, and M F Lokhandwala
January 1980, Horumon to rinsho. Clinical endocrinology,
B S Jandhyala, and P Nandiwada, and J P Buckley, and M F Lokhandwala
September 1979, European journal of pharmacology,
Copied contents to your clipboard!